Riris Istighfari Jenie

12PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGlycoconjugatesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 29, 2026
Agarose-Based 3D Spheroid Model to Evaluate the Anticancer Activity of the Curcumin Analog CCA-1.1 in Triple-Negative Breast Cancer.

|Feb 09, 2026
Investigation of the Anticancer Effects and Senescence Induction of Hesperetin Combined with Cisplatin in Hepatocellular Carcinoma and Embryonic Fibroblast Cell Lines.

Anif Nur Artanti, Riris Istighfari Jenie, Rumiyati Rumiyati

|Dec 29, 2024
Hesperidin and Diosmin Increased Cytotoxic Activity Cisplatin on Hepatocellular Carcinoma and Protect Kidney Cells Senescence.

Anif Nur Artanti, Riris Istighfari Jenie, Rumiyati- Rumiyati

|Nov 29, 2024
Cytoprotective Properties of Turmeric Oil (Curcuma longa L.) on Fibroblast Cells.

Riris Istighfari Jenie, Anif Nur Artanti, Rumiyati Rumiyati

|Aug 29, 2022
Synergistic Cytotoxic and Antimigratory Effect of Brazilein and Doxorubicin on HER2-Overexpressing Cells.

Sri Handayani, Ratna Asmah Susidarti, Rohmad Yudi Utomo

|Aug 08, 2022
Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties.

Rohmad Yudi Utomo, Febri Wulandari, Dhania Novitasari

Pageof 2

Frequent Collaborators

9 joint publications

Edy Meiyanto

6 joint publications

Rohmad Yudi Utomo

3 joint publications

Beni Lestari

3 joint publications

Dhania Novitasari